1. COVID-19 critical illness in pregnancy.
- Author
-
Lapinsky, Stephen E and Al Mandhari, Maha
- Subjects
- *
ADULT respiratory distress syndrome treatment , *INTERLEUKINS , *INTENSIVE care units , *WELL-being , *COVID-19 , *ANTI-inflammatory agents , *PREGNANCY complications , *INFECTIOUS disease transmission , *CRITICAL care medicine , *COVID-19 pandemic , *DISEASE risk factors - Abstract
Although the pregnant population was affected by early waves of the COVID-19 pandemic, increasing transmission and severity due to new viral variants has resulted in an increased incidence of severe illness during pregnancy in many regions. Critical illness and respiratory failure are relatively uncommon occurrences during pregnancy, and there are limited high-quality data to direct management. This paper reviews the current literature on COVID-19 management as it relates to pregnancy, and provides an overview of critical care support in these patients. COVID-19 drug therapy is similar to that used in the non-pregnant patient, including anti-inflammatory therapy with steroids and IL-6 inhibitors, although safety data are limited for antiviral drugs such as remdesivir and monoclonal antibodies. As both pregnancy and COVID-19 are thrombogenic, thromboprophylaxis is essential. Endotracheal intubation is a higher risk during pregnancy, but mechanical ventilation should follow usual principles. ICU management should be directed at optimizing maternal well-being, which in turn will benefit the fetus. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF